EverydayHealth: A novel, nonhormonal medication targeting menopausal vasomotor symptoms may add treatment options for women, research suggests.
Women with hot flashes, take note: there is good news on the horizon. Research presented at the September 2019 annual meeting of the North American Menopause Society (NAMS) showed great promise in fezolinetant, a new, nonhormonal oral medication for women with moderate to severe vasomotor symptoms of menopause (VSM) that is currently under development. READ MORE.
(Source: EverydayHealth, 10/03/2019)